Online citations, reference lists, and bibliographies.
← Back to Search

Modulation Of Phospholipase A2 Activity In Extracts Of Lesion‐free Psoriatic Epidermis By Alkaline Phosphatase And A Protein Phosphatase Inhibitor

P. Cartwright, A. Ilchyshyn, E. Ilderton, H. Yardley
Published 1988 · Biology, Medicine

Cite This
Download PDF
Analyze on Scholarcy
Phospholipase A2 activity is raised in non‐lesional psoriatic epidermis compared with normal epidermis. It has been shown that the activity of this enzyme is controlled by an inhibitory protein the inhibitory effect of which is increased by dephosphorylation. Treatment of epidermal extracts with alkaline phosphatase reduced the phospholipase A2 activity, both in normal and in lesion‐free psoriatic epidermis. Inclusion of pyrophosphate, a protein phosphatase inhibitor, in the homogenizing medium caused the activity of phospholipase A2 in epidermal extracts from normal and lesion‐free epidermis to be raised to the same high level. These results are consistent with the hypothesis that the raised phospholipase A2 activity in psoriatic epidermis is due to hyperphosphorylation of an endogenous inhibitor as a result of defective control of a phosphorylation/dephosphorylation mechanism. The relevance of these findings to other work is discussed.
This paper references
Protein measurement with the Folin phenol reagent.
O. H. Lowry (1951)
Use of Uninvolved Psoriatic Epidermis as an In Vitro Model for Testing the Anti-Phospholipase Activity of Glucocorticoids
A. Ilchyshyn (1986)
Characterisation of a reconstituted Mg-ATP-dependent protein phosphatase.
T. Resink (1983)
Evidence that the phosphorylation of tyrosine is essential for transformation by the Rous sarcoma virus
BM Sefton (1980)
Utilization of epidermal phospholipase A2 inhibition to monitor topical steroid action
J. Norris (1984)
Tyrosine protein kinases.
B. Sefton (1984)
Confirmation of raised phospholipase A2 activity in the uninvolved skin of psoriasis
A. Verhagen (1984)
Identification of several species of phospholipase inhibitory protein(s) by radioimmunoassay for lipomodulin.
F. Hirata (1982)
Protein phosphatase-mediated reversal of Câ •*•-dependent protein phosphorylation
H. Levine (1985)
Cloning and expression of human lipocortin, a phospholipase A2 inhibitor with potential anti-inflammatory activity
B. Wallner (1986)
Characterization of an EGF receptor phosphotyrosyi phosphatase from epidermis
DB Friedman (1987)
Selective dephosphorylation of proteins containing phosphotyrosine by alkaline phosphatases.
G. Swarup (1981)
Inflammation: The mediators of steroid action
R. Flower (1986)
Characterization and activity of phospholipase A2 in normal human epidermis and in lesion‐free epidermis of patients with psoriasis or eczema
S. Forster (1985)
Characterization of lipocortin I and an immunologically unrelated 33-kDa protein as epidermal growth factor receptor/kinase substrates and phospholipase A2 inhibitors.
H. Haigler (1987)
Partial characterization of phospholipase C activity in normal, psoriatic uninvolved, and lesional epidermis.
R. Bartel (1987)
Cutaneous alkaline phosphatase: A biochemical study
P. Mier (2004)
Epidermal growth factor-dependent phosphorylation of lipocortin
R. Pepinsky (1986)
Regulation of protein phosphatase i by tyrosine protein kinases
TS Ingebritsen (1985)
Protein phosphatase-mediated reversal of Ca^ •*•-dependent protein phosphorylation
H Levine (1985)
Evidence that the phosphorylation of tyrosine is essential for cellular transformation by Rous sarcoma virus
B. Sefton (1980)
The mediators of steroid action.
R. Flower (1986)

This paper is referenced by
Semantic Scholar Logo Some data provided by SemanticScholar